Marta Casado
Overview
Explore the profile of Marta Casado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Recompensation of decompensated cirrhosis in hepatitis C patients after SVR: Prognostic implications
Sanchez-Torrijos Y, Fernandez-Alvarez P, Rosales J, Perez-Estrada C, Alanon-Martinez P, Rodriguez-Peralvarez M, et al.
J Hepatol
. 2025 Mar;
PMID: 40056934
Backgound&aims: The Baveno VII consensus introduced the term "recompensated cirrhosis," though few studies have examined its clinical relevance. We analyzed the rate and predictors of recompensation in hepatitis C (HCV)...
2.
Ricarte M, Portugal J, Amato F, van Drooge B, Jaen C, Pyambri M, et al.
Sci Total Environ
. 2025 Jan;
963():178435.
PMID: 39827641
Airborne quasi-ultrafine particle samples were collected from different outdoor sites in Barcelona (NE Spain, 35 samples) and the Valencia subway (about 400 km south of Barcelona, 3 samples). Locations and...
3.
Cruz-Ojeda P, Navarro-Villaran E, Fuertes-Agudo M, Mata A, Lopez-Lluch G, Navas P, et al.
Free Radic Biol Med
. 2025 Jan;
229:251-263.
PMID: 39743028
Background: Sorafenib is a tyrosine kinase inhibitor (TKI) that belongs to the landscape of treatments for advanced stages of hepatocellular carcinoma (HCC). The induction of cell death and cell cycle...
4.
Abbassi A, Kessabi K, Casado M, Perez-Jimenez A, Trenzado C, Rufino-Palomares E, et al.
Chemosphere
. 2024 Nov;
368:143783.
PMID: 39577801
Estuaries and lagoons are characterized by fluctuating salinity and significant amounts of microplastics (MPs) and are increasingly subjected to various anthropogenic pressures. We investigated whether the accumulation of MPs in...
5.
Moro H, Vaya R, Casado M, Pina B, Dominguez-Garcia P, Gomez-Canela C, et al.
Chemosphere
. 2024 Oct;
367:143612.
PMID: 39447773
A cost-effective Daphnia magna testing framework was applied to identify emerging hazards such as neurological and cardiovascular defects as well as antibiotic resistant genes (ARGs), related to pharmaceuticals present in...
6.
Sanz C, Casado M, Martinez-Landa L, Valhondo C, Amalfitano S, Di Pippo F, et al.
Sci Total Environ
. 2024 Sep;
953:176078.
PMID: 39244046
Soil Aquifer Treatment (SAT) is a robust technology to increase groundwater recharge and to improve reclaimed water quality. SAT reduces dissolved organic carbon, contaminants of emerging concern, nutrients, and colloidal...
7.
Rodriguez-Tajes S, Palom A, Giraldez-Gallego A, Moreno A, Urquijo J, Rodriguez M, et al.
Gastroenterol Hepatol
. 2024 Jun;
48(2):502222.
PMID: 38908682
Background And Aims: Chronic hepatitis D (CHD) is a severe form of chronic viral hepatitis. The estimated hepatitis delta prevalence in Spain is around 5% of patients with hepatitis B....
8.
Brea R, Casanova N, Alvarez-Lucena C, Fuertes-Agudo M, Luque-Tevar M, Cucarella C, et al.
Liver Int
. 2024 Jun;
44(9):2409-2423.
PMID: 38847511
Background And Aims: Cyclooxygenase-2 (COX-2) is involved in different liver diseases, but little is known about the significance of COX-2 in cholestatic injury. This study was designed to elucidate the...
9.
De Vincentis A, Ampuero J, Terracciani F, DAmato D, Gerussi A, Cristoferi L, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(10):2062-2074.e11.
PMID: 38782175
Background & Aims: Obeticholic acid (OCA) is the only licensed second-line therapy for primary biliary cholangitis (PBC). With novel therapeutics in advanced development, clinical tools are needed to tailor the...
10.
Ampuero J, Lucena A, Berenguer M, Hernandez-Guerra M, Molina E, Gomez-Camarero J, et al.
Hepatology
. 2024 Mar;
80(4):791-806.
PMID: 38447019
Background And Aims: The landscape in primary biliary cholangitis (PBC) has changed with the advent of second-line treatments. However, the use of obeticholic acid (OCA) and fibrates in PBC-related cirrhosis...